Tissue microarray study for classification of breast tumors

Life Sciences

Volumn 73, Issue 25, 2003, Pages 3189-3199

  Zhang, Dao Hai ^a,b   Salto Tellez, Manuel ^a,b   Chiu, Lily Lily ^a   Shen, Liang ^c   Koay, Evelyn Siew Chuan ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c MINISTRY OF HEALTH   (Singapore)

Author keywords

Breast cancer; Immunohistochemistry; Tissue microarray; Tumor classification

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; PROTEIN P53; VASCULOTROPIN;

ADULT; ALGORITHM; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; ONCOGENE NEU; PHENOTYPE; STATISTICAL ANALYSIS;

EID: 0141927384     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.05.006     Document Type: Article

References (30)

1. Ahr A., Holtrich U., Solbach C., Scharl A., Strebhardt K., Karn T., Kaufmann M. Molecular classification of breast cancer patients by gene expression profiling. Journal of Pathology. 195(3):2001;312-320.
2. Alaiya A.A., Franzen B., Hagman A., Dysvik B., Roblick U.J., Becker S., Moberger B., Auer G., Linder S. Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. International Journal of Cancer. 98(6):2002;895-899.
3. Bertucci F., Houlgatte R., Benziane A., Granjeaud S., Adélaïde J., Tagett R., Loriod B., Jacquemier J., Viens P., Jordan B., Birnbaum D., Nguyen C. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Human Molecular Genetics. 9(20):2000;2981-2991.
4. Brown M.P., Grundy W.N., Lin D., Cristianini N., Sugnet C.W., Furey T.S., Ares M. Jr., Haussler D. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA. 97(1):2000;262-267.
5. Callagy G., Cattaneo E., Yataro D., Happerfield L., Bobrow L., Pharoah P.D.P., Cardas C. Molecular classification of breast carcinomas using tissue microarray. Diagnostic Molecular Pathology. 12(1):2003;27-34.
6. Carter W.B., Hoying J.B., Boswell C., Williams S.K. HER2/neu overexpression induces endothelial cell retraction. International Journal of Cancer. 91(3):2001;295-299.
7. Clark J., Edwards S., John M., Flohr P., Gordon T., Maillard K., Giddings I., Brown C., Bagherzadeh A., Campbell C., Shipley J., Wooster R., Cooper C.S. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes, Chromosomes and Cancer. 34(1):2002;104-114.
8. Covell D.G., Wallqvist A., Rabow A.A., Thanki N. Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data. Molecular Cancer Therapy. 2(3):2003;317-332.
9. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95(25):1998;14863-14868.
10. Ferrandina G., Ranelletti F.O., Lauriola L., Fanfani F., Legge F., Mottolese M., Nicotra M.R., Natali P.G., Zakut V.H., Scambia G. Cyclooxygenase-2 (Cox-2), epidermal growth factor receptor (EGFR), and HER-2/ neu expression in ovarian cancer. Gynecologic Oncology. 85(2):2002;305-310.
11. Fujiwaki R., Hata K., Iida K., Maede Y., Watanabe Y., Koike M., Miyazaki K. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer. Acta Obstet Gynecol Scand. 78(8):1999;728-734.
12. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537.
13. Iwao K., Matoba R., Ueno N., Ando A., Miyoshi Y., Matsubara K., Noguchi S., Kato K. Molecular classification of primary breast tumors possessing distinct prognostic properties. Human Molecular Genetics. 11(2):2002;199-206.
14. Jiang Y., Harlocker S.L., Molesh D.A., Dillon D.C., Stolk J.A., Houghton R.L., Repasky E.A., Badaro R., Reed S.G., Xu J. Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene. 21(14):2002;2270-2282.
15. Jones K.A., Brown M.A., Solomon E. Molecular genetics of sporadic and familial breast cancer. Cancer Surveys. 25:1995;315-334.
16. Kauranemi P., Barlund M., Monni O., Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Research. 61(22):2001;8235-8240.
17. Klauber-DeMore N., Tan L.K., Liberman L., Kaptain S., Fey J., Borgen P., Heerdt A., Montgomery L., Paglia M., Petrek J.A., Cody H.S., Van Zee K.J. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Annals of Surgical Oncology. 7(9):2000;636-642.
18. Monni O., Barlund M., Mousses S., Kononen J., Sauter G., Heiskanen M., Paavola P., Avela K., Chen Y., Bittner M.L., Kallioniemi A. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA. 98(10):2001;5711-5716.
19. Niijima M., Yamaguchi T., Ishihara T., Hara T., Kato K., Kondo F., Saisho H. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas. Cancer. 94:2002;1565-1573.
20. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., Pergamenschikov A., Williams C.F., Zhu S., Lee J.C.F., Lashkari D., Shalon D., Brown P.O., Botstein D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA. 96(16):1999;9212-9217.
21. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S., Lønning P.E., Børresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumors. Nature. 406(4797):2000;747-752.
22. Rajnakova A., Moochhala S., Goh P.M.Y., Ngoi S.S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Letters. 172(2):2001;177-185.
23. Ristimaki A., Sivula A., Lundin J., Salminen T., Haglund C., Joensuu H., Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Research. 62(3):2002;632-635.
24. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Lønning P.E., Børresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad Sci USA. 98(19):2001;10869-10874.
25. Spencer K.S., Graus-Porta D., Leng J., Hynes N.E., Klemke R.L. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinase. Journal of Cell Biology. 148:2000;385-397.
26. Tamayo P., Slonim D., Misirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E.S., Golub T.R. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA. 96(6):1999;2907-2912.
27. Tavazoie S., Hughes J.D., Campbell M.J., Cho R.J., Church G.M. Systematic determination of genetic network architecture. Nature Genetics. 22(3):1999;281-285.
28. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415(6871):2002;530-536.
29. Zhang D.-H., Salto-Tellez M., Putti T.C., Do E., Koay E.S.C. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Modern Pathology. 16(1):2003;79-85.
30. Zhang D.-H., Salto-Tellez M., Do E., Putti T.C., Koay E.S.C. Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays. Human Pathology. 34(4):2003;362-368.